As of May 22
| -0.03 / -0.72%|
The 4 analysts offering 12-month price forecasts for CytRx Corp have a median target of 9.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +118.45% increase from the last price of 4.12.
The current consensus among 4 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.